Nijhawan Pardeep 4
4 · Edesa Biotech, Inc. · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
Edesa Biotech CEO Pardeep Nijhawan Receives RSU Award
What Happened
Pardeep Nijhawan, CEO of Edesa Biotech, was granted 2,578 restricted share units (RSUs) that vested in full upon grant under the Issuer's 2019 Equity Incentive Compensation Plan. The acquisition is reported at $0.00 per share on the Form 4 (transaction code A — Award/Grant).
Key Details
- Transaction date: 2026-04-01 (grant that vested in full upon grant)
- Reported acquisition: 2,578 shares; reported price $0.00 per share
- Filing date: Form 4 filed 2026-04-10 (appears late relative to the April 1 transaction)
- Shares owned after transaction: not specified in the provided filing
- Footnotes: F1 confirms RSUs vested in full upon grant under the 2019 Equity Incentive Compensation Plan. F2 and F3 note entities wholly owned by the reporting person and a co-trustee status; the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.
Context
This was a compensation award (RSUs that vested on grant), not an open-market purchase or sale. Such grants reflect compensation/long-term incentives rather than an immediate trading decision and should not be interpreted by themselves as a bullish or bearish signal.
Insider Transaction Report
Form 4
Nijhawan Pardeep
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Shares
[F1]2026-04-01+2,578→ 631,391 total
Holdings
- 402,702(indirect: Held by Pardeep Nijhawan Medicine Professional Corporation)
Common Shares
[F2] - 32,609(indirect: By Trust)
Common Shares
[F3] - 32,013(indirect: Held by The Digestive Health Clinic Inc.)
Common Shares
[F2] - 53,104(indirect: Held by 1968160 Ontario Inc.)
Common Shares
[F2]
Footnotes (3)
- [F1]Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
- [F2]Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan|2026-04-10